Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Nintedanib/anticoagulants

Haematochezia and epistaxis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Allione A, et al. Risk of Bleeding with Antifibrotic Drugs in Combination with Anticoagulants or Antiplatelets. Respiration 102: 682-683 abstr. 70, Sep 2023. Available from: URL: https://dx.doi.org/10.1159/000531211 [abstract] Allione A, et al. Risk of Bleeding with Antifibrotic Drugs in Combination with Anticoagulants or Antiplatelets. Respiration 102: 682-683 abstr. 70, Sep 2023. Available from: URL: https://dx.doi.org/10.1159/000531211 [abstract]
Metadaten
Titel
Nintedanib/anticoagulants
Haematochezia and epistaxis
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57738-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Argatroban